Rare Ovarian Cancer GOG 260
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary
Peritoneal Cancer.